2017 American Transplant Congress
Trends in Liver Transplantation Among Older Adults with ESLD.
1Surgery, JHU, Baltimore; 2Epidemiology, JHU, Baltimore
As the population ages and as the average age of liver transplant (LT) waitlist candidates increases, understanding of the trends and outcomes is imperative for…2017 American Transplant Congress
Dementia and Alzheimer's Disease Among Older Kidney Transplant Recipients.
Background: Kidney transplantation (KT) is a growing treatment option for older ESRD patients. Older recipients may develop post-KT dementia and Alzheimer's disease (AD) associated with…2017 American Transplant Congress
Is It Safe to Use Older Donor Liver Grafts for Older Recipients?
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
Aim: The safety of liver transplantation (LT) using older donor grafts into older recipients remains to be elucidated. The aim of this study was to…2017 American Transplant Congress
EPTS Is a Poor Predictor of Post-KT Mortality for Older Recipients.
Background:The new kidney allocation system (KAS) is meant to better match longevity of recipients and allografts. The United Network for Organ Sharing (UNOS) decided that…2017 American Transplant Congress
Clinical Outcome of Pancreas Transplantation in Elderly Patients with Diabetes Mellitus.
Introduction: The age of the recipient is an important factor affecting the outcome of pancreas transplantation. In elderly people, it was a taboo due to…2017 American Transplant Congress
Is Reluctance to Accept Younger Kidney Donors Justified?
1U of MN, Mpls; 2M Health, Mpls
Transplant centers are often reluctant to accept young kidney donors because of long-term concerns regarding reduced renal mass and because they have not yet reached…2017 American Transplant Congress
CD4+IFN-γ+IL-10+ Regulatory Type 1 Cells Facilitate Prolongation of Graft Survival in Old Recipient Mice Treated with Rapamycin.
Although the elderly represent a rapidly growing population among transplant recipients, age-specific aspects have not been considered sufficiently in clinical trials. Moreover, age-specific effects of…2016 American Transplant Congress
Defining Frailty in Liver Transplant Recipients.
PURPOSETo define frailty in the liver transplant (OLT) population to optimize care and assist in predicting post OLT outcomes.METHODSAll adult primary OLT patients from 01/2010…2016 American Transplant Congress
Induction Agent Use and Outcomes in Older KT Recipients: Patient and Center Level Associations.
Background: Clinical trials of induction agents typically exclude older recipients, so our practice in older recipients is extrapolated from this. Older adults are different, so…2016 American Transplant Congress
C1-Inhibitor Abrogated Ischemia/Reperfusion (I/R) Induced Inflammaging by Inhibiting Senescence-Associated Secretory Phenotype (SASP) in Tubular Epithelial Cells (TEC).
Inflammaging is a pathogenic process usually associated with chronic kidney disease such as diabetic nephropathy where TEC cells have a diminished regenerative potential and develop…
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 24
- Next Page »